USPTO trademark

RELIZORB

RegisteredUSPTOWord markClass 5Class 10

"RELIZORB" is a word mark owned by Alcresta Therapeutics, Inc., filed at the USPTO on July 13, 2015. It is registered and covers classes 5 and 10.

Official USPTO record
RELIZORB trademark as filed
As filed with the USPTO
Status
Registered
Since August 5, 2026
Filed
July 13, 2015
Registered
November 22, 2016
Expires
Not recorded
Application no.
86690981
Registration no.
5087672
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns RELIZORB

The owner and representative on file with the office.

Owner

Alcresta Therapeutics, Inc.

Waltham, United States

Representative

Perry J. Viscounty, Esq.

Latham & Watkins LLP

Goods and services

What the mark covers

The products and services RELIZORB is filed for, grouped by Nice class.

  • Medical nutritional formula, namely, formula for use as a nutritional supplement; infant formula; dietetic foods adapted for medical use; enzymes for medical purposes; dietary and nutritional supplements; pharmaceutical preparations for the treatment of nutritional, gastrointestinal, digestive, metabolic, urological, nephrology, endocrine, oncologic, rheumatologic, inflammatory, pediatric, elderly, immunologic, cardiovascular, dermatologic, hematologic, infectious, circulatory, surgery and would healing, mental illness, pulmonary, muscular and respiratory diseases and disorders

  • Filters for medical purposes, namely, for processing and converting medical nutritional formula

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of acceptance of sec. 8 & 9 - e-mailed
  2. Registered and renewed (first renewal - 10 yrs)
  3. Registered - sec. 8 (10-yr) accepted/sec. 9 granted
  4. Case assigned to post registration paralegal
  5. Teas section 8 & 9 received
  6. Courtesy reminder - sec. 8 (10-yr)/sec. 9 e-mailed
  7. Assignment of ownership not updated automatically
  8. Teas change of correspondence received
  9. Attorney/dom.rep.revoked and/or appointed
  10. Teas revoke/app/change addr of atty/dom rep received

10 earlier steps on the official record.

FAQ

About RELIZORB

Who owns the trademark "RELIZORB"?

The USPTO trademark "RELIZORB" (application 86690981) is owned by Alcresta Therapeutics, Inc.

What is the status of "RELIZORB"?

Its status at the USPTO is: registered.

When was "RELIZORB" registered?

It was registered on November 22, 2016.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RELIZORB and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2874-73a2-75dc-bdf0-a24111d45a96
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2874-73a2-75dc-bdf0-a24111d45a96",
  "object": "trademark",
  "mark_text": "RELIZORB",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "86690981",
  "filing_date": "2015-07-13",
  "nice_classes": [
    5,
    10
  ],
  "owners": [
    {
      "name": "ALCRESTA THERAPEUTICS, INC.",
      "entity_id": null
    }
  ]
}